about
Oral acyclovir suppression and neurodevelopment after neonatal herpesRotavirus vaccines: an overviewRotavirus infection: an update on management and preventionSerum antibody responses in children with rotavirus diarrhea can serve as proxy for protectionViral gastroenteritis in children.Rotavirus vaccine and intussusception. Where do we go from here?Rotavirus Infection: A Disease of the Past?Valganciclovir for symptomatic congenital cytomegalovirus diseaseRotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.Rotavirus vaccines: an update.Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countriesAcute diarrheal disease in children: epidemiology, prevention, and treatment.Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.Cytokines as mediators for or effectors against rotavirus disease in children.Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.Moving toward elimination of healthcare-associated infections: a call to action.Effects of vaccine on rotavirus disease in the pediatric population.Antigenemia, RNAemia, and innate immunity in children with acute rotavirus diarrhea.Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness.The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.First detection of group C rotavirus in fecal specimens of children with diarrhea in the United States.Treatment and prevention of rotavirus infection in children.Ten year follow-up of healthy children who received one or two injections of varicella vaccine.Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States.Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.Prevalence and Characteristics of Human Metapneumovirus Infection Among Hospitalized Children at High Risk for Severe Lower Respiratory Tract Infection.Safety and immunogenicity of palivizumab (Synagis) administered for two seasons.Serologic responses by immunoblot following natural infection with rotavirus serotypes G1 and G4 in children.Prevalence of group C rotavirus among children in Rhode Island, United States.A Prospective Case‐Control Study of the Role of Astrovirus in Acute Diarrhea among Hospitalized Young ChildrenEfficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)Moving toward Elimination of Healthcare-Associated Infections: A Call to ActionRotavirus vaccines—An update
P50
Q24615077-24072633-DA5A-4539-9335-C0B933648D4AQ24657750-32179450-27DF-4FBE-BDD2-A564B5FCC7A0Q28270926-184E3E44-B7B4-458E-A66B-72613C8BCD97Q33859304-8E8DCF10-E425-4206-B597-FEBFF944C580Q34155941-5B9B6F95-3F93-4752-ADFF-DDD67A5CCF07Q34218585-EDC444C2-40DC-4B47-9C53-06D0AC32A7C6Q34492386-63D3A4A1-33FE-4BB6-B7F9-98E2ECD76EE5Q35465712-E92FF112-5F57-4F5D-9562-E84FCF3B7103Q35785249-631B268C-81B0-4831-8416-56956EC4B938Q36014278-7AF4158B-3402-43C1-A987-6601ECE2AC14Q36175693-6BF9BB9D-A2F6-49ED-A646-F25426FB2151Q36231213-232E34EA-6A95-48E5-B171-7EC44CA1A3C6Q36978394-86BF51C7-E56F-4734-A072-E7ABEB3501B4Q36992562-FBE5906F-F25B-4A2E-806F-D30491CA0812Q37057582-41FA8E2E-58DB-44AC-AEB4-8D23445A675CQ37452293-BD1A00CC-BA26-4893-AB8A-93D93452461AQ37807970-1950D6A9-6D73-4358-90FC-61E62E094B6BQ37970565-2F3DEB62-1F28-4BEC-8A43-1A8F3D614B9DQ38467394-B90FD5DA-CA57-4EBF-AA70-CFD2EB04C7C6Q40044219-16327C47-9CEA-4A88-92FF-670229BDE001Q40425249-841F1CEF-B6DE-49E3-A926-8D93417A2F1BQ40489497-3FDBEE64-3853-42AB-9D88-A584AF0D0FC3Q40507053-9FA18448-2EBC-489C-BCB1-F751848E2942Q40540984-847C52EF-05D1-4361-BFF3-4CE4644EAFACQ40548550-09474215-96A3-4CDF-B0A1-01D5C1110464Q40661937-5A938881-F783-4637-80EB-F2F82908A899Q40979866-2CFC6A8A-8234-4E0D-BE60-917F6831DAB4Q42269528-36B50F89-88D8-4E85-9DFD-0D15D8B04C57Q44793181-79CB4E6E-0D99-417F-822A-9E52EE0BB24FQ45039647-7B3C095A-01E8-4ED2-9CE1-27E3F5AC0896Q45752849-865F064D-3904-4890-9430-99EC0A4FEBCDQ45835308-6BD46B78-A632-4FCF-9DB5-F202C2CD2CC7Q46354040-8CA193EF-856D-4034-ABC5-B81A402B4CDBQ47692412-78D6EB64-8F88-4976-88FC-5ED36DBB188DQ47699682-8DD8F084-D1F4-413C-88EA-98717B9FB70DQ54539866-411E052E-7BD6-4726-A1A0-5F014AE8AD5FQ57661858-E5011CBE-8744-4698-A363-D679EE33CB73Q58289405-CADD322C-FD44-4B3A-917D-219EAA7BA3A2Q58289435-5C3E117A-CBD2-4823-89C4-4A30A90BDF95Q58289569-3C6CB653-ECFB-40AD-A750-74909EA80EE9
P50
description
kinderarts
@nl
pediatrician
@en
name
Penelope H Dennehy
@nl
Penelope H Dennehy
@sl
Penelope H. Dennehy
@en
Penelope H. Dennehy
@es
type
label
Penelope H Dennehy
@nl
Penelope H Dennehy
@sl
Penelope H. Dennehy
@en
Penelope H. Dennehy
@es
altLabel
Penelope Hill
@en
prefLabel
Penelope H Dennehy
@nl
Penelope H Dennehy
@sl
Penelope H. Dennehy
@en
Penelope H. Dennehy
@es
P106
P1153
7003421588
P2038
Penelope_Dennehy
P21
P31
P496
0000-0002-2259-5370
P6634
penelope-dennehy-33406b19